文献速递呼吸道感染呼吸危重症与机械通气

ICU成人呼吸道合胞病毒与流感感染特征及结局的多中心匹配队列研究

Characteristics and Outcomes of Patients in the ICU With Respiratory Syncytial Virus Compared With Those With Influenza Infection: A Multicenter Matched Cohort Study.
PubMed 文献 · Chest · 2022-01-19

这项在法国和比利时17个中心开展的回顾性匹配队列研究,比较了2011年11月至2018年4月ICU成人呼吸道合胞病毒(RSV)感染与流感感染患者的特征和结局。

要点

  • ICU成人RSV感染患者慢性呼吸系统疾病和免疫抑制比例显著高于流感患者。
  • RSV组院内死亡率达23.9%,与流感组25.6%相比无显著差异。
  • 多因素校正后RSV感染与流感感染的院内死亡 odds 相似。

核心结论

  • ICU成人RSV感染与流感感染在合并症和诊断时特征上存在差异。
  • RSV感染与较高的院内死亡率相关,接近25%。
  • 多因素分析中,RSV感染与流感感染的院内死亡 odds 相似。

研究设计与样本

  • 回顾性、多中心研究,在法国和比利时17个中心开展。
  • 比较2011年11月至2018年4月ICU成人RSV感染与流感感染患者的特征和结局。
  • 每例RSV感染患者按机构和诊断日期与一例流感感染患者匹配。
  • 共分析618例患者(309例RSV感染,309例流感感染)。
  • 院内死亡率比较采用多因素模型校正预后因素(性别、年龄、主要基础疾病和并发血流感染)。

主要发现

  • RSV组有基础慢性呼吸系统疾病的比例显著高于流感组(60.2% vs 40.1%;P < .001)。
  • RSV组免疫抑制比例显著高于流感组(35% vs 26.2%;P = .02)。
  • 两组诊断时临床体征和生物学数据存在若干差异。
  • 院内死亡率两组无显著差异(RSV组23.9% vs 流感组25.6%;P = .63)。
  • 多因素模型校正预后因素后,院内死亡率仍无显著差异。

关键数值与推荐

  • RSV组慢性呼吸系统疾病比例60.2%,流感组40.1%(P < .001)。
  • RSV组免疫抑制比例35%,流感组26.2%(P = .02)。
  • RSV组院内死亡率23.9%,流感组25.6%(P = .63)。

临床怎么用

  • ICU成人RSV感染患者应关注慢性呼吸系统疾病和免疫抑制等基础状况。
  • RSV感染在ICU成人中可导致高院内死亡率,临床需重视。
  • RSV与流感感染在ICU的院内死亡风险相似,治疗决策可参考流感经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The characteristics and outcomes of adult patients with respiratory syncytial virus (RSV) infection who require ICU admission are poorly defined. Although several studies in adults with RSV infection have been published in recent years, they did not focus specifically on patients with critical illness. RESEARCH QUESTION: What are the characteristics and outcomes of adult patients in the ICU with RSV infection and how do they compare with those of patients in the ICU with influenza infection? STUDY DESIGN AND METHODS: This retrospective, multicenter study in France and Belgium (17 sites) compared the characteristics and outcomes of adult patients in the ICU with RSV infection vs those with influenza infection between November 2011 and April 2018. Each patient with RSV infection was matched by institution and date of diagnosis with a patient with influenza infection. In-hospital mortality was compared between the two groups, with adjustment for prognostic factors in a multivariate model (sex, age, main underlying conditions, and concurrent bloodstream infection). RESULTS: Data from 618 patients (309 with RSV infection and 309 with influenza infection) were analyzed. Patients with RSV infection were significantly more likely to have an underlying chronic respiratory condition (60.2% vs 40.1%; P < .001) and to be immunocompromised (35% vs 26.2%; P = .02) than patients with influenza infection. Several differences in clinical signs and biological data at diagnosis were found between the groups. In-hospital mortality was not significantly different between the two groups (23.9% in the RSV group vs 25.6% in the influenza group; P = .63), even after adjustment for prognostic factors in a multivariate model. INTERPRETATION: Adult patients in the ICU with RSV infection differ from adult patients in the ICU with influenza in terms of comorbidities and characteristics at diagnosis. RSV infection was associated with high in-hospital mortality, approaching 25%. In multivariate analysis, RSV infection was associated with a similar odds of in-hospital death compared with influenza infection.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Coussement J, Zuber B, Garrigues E, et al. Characteristics and Outcomes of Patients in the ICU With Respiratory Syncytial Virus Compared With Those With Influenza Infection: A Multicenter Matched Cohort Study. Chest. 2022. PMID: 35063450. doi:10.1016/j.chest.2021.12.670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。